More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.
Novo Nordisk said on Monday (Nov 18) it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market. A spokesperson for the Danish drugmaker confirmed the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback